This conserved lipid acyltransferase has many re-entrant segments but only one true TM helix. Most closely related to bacterial acyltransferases.. Heavily expanded in kinetoplastids for unknown reasons. Localization: ER (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 45 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 29 |
NetGPI | no | yes: 0, no: 29 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 23 |
GO:0110165 | cellular anatomical entity | 1 | 23 |
Related structures:
AlphaFold database: E9ALJ6
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 4 |
GO:0006644 | phospholipid metabolic process | 4 | 4 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 4 |
GO:0006654 | phosphatidic acid biosynthetic process | 6 | 4 |
GO:0006793 | phosphorus metabolic process | 3 | 4 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 4 |
GO:0008152 | metabolic process | 1 | 4 |
GO:0008610 | lipid biosynthetic process | 4 | 4 |
GO:0008654 | phospholipid biosynthetic process | 5 | 4 |
GO:0009058 | biosynthetic process | 2 | 4 |
GO:0009987 | cellular process | 1 | 4 |
GO:0019637 | organophosphate metabolic process | 3 | 4 |
GO:0044237 | cellular metabolic process | 2 | 4 |
GO:0044238 | primary metabolic process | 2 | 4 |
GO:0044249 | cellular biosynthetic process | 3 | 4 |
GO:0044255 | cellular lipid metabolic process | 3 | 4 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 4 |
GO:0046473 | phosphatidic acid metabolic process | 6 | 4 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 4 |
GO:0046486 | glycerolipid metabolic process | 4 | 4 |
GO:0071704 | organic substance metabolic process | 2 | 4 |
GO:0090407 | organophosphate biosynthetic process | 4 | 4 |
GO:1901576 | organic substance biosynthetic process | 3 | 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 30 |
GO:0016740 | transferase activity | 2 | 30 |
GO:0016746 | acyltransferase activity | 3 | 30 |
GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity | 7 | 6 |
GO:0008374 | O-acyltransferase activity | 5 | 6 |
GO:0016411 | acylglycerol O-acyltransferase activity | 6 | 6 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 6 |
GO:0042171 | lysophosphatidic acid acyltransferase activity | 6 | 6 |
GO:0071617 | lysophospholipid acyltransferase activity | 5 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.525 |
CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.308 |
CLV_PCSK_FUR_1 | 291 | 295 | PF00082 | 0.646 |
CLV_PCSK_KEX2_1 | 293 | 295 | PF00082 | 0.594 |
CLV_PCSK_PC1ET2_1 | 293 | 295 | PF00082 | 0.605 |
CLV_PCSK_SKI1_1 | 218 | 222 | PF00082 | 0.489 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.255 |
DOC_MAPK_DCC_7 | 21 | 30 | PF00069 | 0.544 |
DOC_MAPK_gen_1 | 174 | 182 | PF00069 | 0.291 |
DOC_MAPK_gen_1 | 21 | 29 | PF00069 | 0.508 |
DOC_MAPK_HePTP_8 | 28 | 40 | PF00069 | 0.450 |
DOC_MAPK_MEF2A_6 | 176 | 184 | PF00069 | 0.215 |
DOC_MAPK_MEF2A_6 | 21 | 30 | PF00069 | 0.509 |
DOC_MAPK_MEF2A_6 | 31 | 40 | PF00069 | 0.475 |
DOC_MAPK_MEF2A_6 | 83 | 91 | PF00069 | 0.303 |
DOC_PP4_FxxP_1 | 162 | 165 | PF00568 | 0.168 |
DOC_USP7_UBL2_3 | 135 | 139 | PF12436 | 0.224 |
DOC_USP7_UBL2_3 | 282 | 286 | PF12436 | 0.258 |
DOC_USP7_UBL2_3 | 293 | 297 | PF12436 | 0.303 |
DOC_WW_Pin1_4 | 161 | 166 | PF00397 | 0.245 |
DOC_WW_Pin1_4 | 202 | 207 | PF00397 | 0.262 |
LIG_14-3-3_CanoR_1 | 2 | 7 | PF00244 | 0.323 |
LIG_14-3-3_CanoR_1 | 294 | 300 | PF00244 | 0.378 |
LIG_14-3-3_CanoR_1 | 31 | 37 | PF00244 | 0.488 |
LIG_14-3-3_CanoR_1 | 83 | 88 | PF00244 | 0.423 |
LIG_APCC_ABBA_1 | 170 | 175 | PF00400 | 0.187 |
LIG_BRCT_BRCA1_1 | 113 | 117 | PF00533 | 0.192 |
LIG_BRCT_BRCA1_1 | 192 | 196 | PF00533 | 0.330 |
LIG_BRCT_BRCA1_1 | 96 | 100 | PF00533 | 0.248 |
LIG_CSL_BTD_1 | 238 | 241 | PF09270 | 0.360 |
LIG_FHA_1 | 203 | 209 | PF00498 | 0.313 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.327 |
LIG_LIR_Gen_1 | 114 | 123 | PF02991 | 0.276 |
LIG_LIR_Gen_1 | 252 | 262 | PF02991 | 0.360 |
LIG_LIR_Gen_1 | 97 | 105 | PF02991 | 0.317 |
LIG_LIR_Nem_3 | 114 | 120 | PF02991 | 0.298 |
LIG_LIR_Nem_3 | 168 | 173 | PF02991 | 0.344 |
LIG_LIR_Nem_3 | 216 | 220 | PF02991 | 0.272 |
LIG_LIR_Nem_3 | 252 | 257 | PF02991 | 0.359 |
LIG_LIR_Nem_3 | 5 | 9 | PF02991 | 0.452 |
LIG_LIR_Nem_3 | 97 | 103 | PF02991 | 0.323 |
LIG_MLH1_MIPbox_1 | 113 | 117 | PF16413 | 0.187 |
LIG_Pex14_2 | 158 | 162 | PF04695 | 0.287 |
LIG_SH2_CRK | 254 | 258 | PF00017 | 0.301 |
LIG_SH2_SRC | 93 | 96 | PF00017 | 0.222 |
LIG_SH2_STAP1 | 34 | 38 | PF00017 | 0.386 |
LIG_SH2_STAT5 | 130 | 133 | PF00017 | 0.276 |
LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.253 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.295 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.279 |
LIG_SH2_STAT5 | 254 | 257 | PF00017 | 0.327 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.396 |
LIG_SH2_STAT5 | 93 | 96 | PF00017 | 0.399 |
LIG_SH3_1 | 244 | 250 | PF00018 | 0.330 |
LIG_SH3_3 | 235 | 241 | PF00018 | 0.287 |
LIG_SH3_3 | 244 | 250 | PF00018 | 0.305 |
LIG_SUMO_SIM_par_1 | 285 | 292 | PF11976 | 0.270 |
LIG_SUMO_SIM_par_1 | 50 | 56 | PF11976 | 0.299 |
LIG_TRAF2_1 | 264 | 267 | PF00917 | 0.304 |
LIG_WRC_WIRS_1 | 134 | 139 | PF05994 | 0.279 |
LIG_WRC_WIRS_1 | 214 | 219 | PF05994 | 0.280 |
LIG_WRC_WIRS_1 | 75 | 80 | PF05994 | 0.299 |
MOD_CK1_1 | 138 | 144 | PF00069 | 0.198 |
MOD_CK1_1 | 216 | 222 | PF00069 | 0.300 |
MOD_CK1_1 | 242 | 248 | PF00069 | 0.266 |
MOD_CK1_1 | 271 | 277 | PF00069 | 0.401 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.441 |
MOD_CK1_1 | 99 | 105 | PF00069 | 0.318 |
MOD_CK2_1 | 160 | 166 | PF00069 | 0.194 |
MOD_CK2_1 | 99 | 105 | PF00069 | 0.367 |
MOD_GlcNHglycan | 302 | 305 | PF01048 | 0.656 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.269 |
MOD_GSK3_1 | 186 | 193 | PF00069 | 0.367 |
MOD_GSK3_1 | 94 | 101 | PF00069 | 0.345 |
MOD_N-GLC_1 | 202 | 207 | PF02516 | 0.462 |
MOD_N-GLC_2 | 108 | 110 | PF02516 | 0.406 |
MOD_NEK2_1 | 111 | 116 | PF00069 | 0.251 |
MOD_NEK2_1 | 147 | 152 | PF00069 | 0.289 |
MOD_NEK2_1 | 60 | 65 | PF00069 | 0.310 |
MOD_NEK2_1 | 98 | 103 | PF00069 | 0.394 |
MOD_NEK2_2 | 112 | 117 | PF00069 | 0.275 |
MOD_NEK2_2 | 192 | 197 | PF00069 | 0.215 |
MOD_PIKK_1 | 298 | 304 | PF00454 | 0.298 |
MOD_PIKK_1 | 63 | 69 | PF00454 | 0.355 |
MOD_Plk_4 | 112 | 118 | PF00069 | 0.270 |
MOD_Plk_4 | 147 | 153 | PF00069 | 0.273 |
MOD_Plk_4 | 192 | 198 | PF00069 | 0.180 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.385 |
MOD_Plk_4 | 216 | 222 | PF00069 | 0.326 |
MOD_Plk_4 | 252 | 258 | PF00069 | 0.193 |
MOD_Plk_4 | 295 | 301 | PF00069 | 0.386 |
MOD_Plk_4 | 42 | 48 | PF00069 | 0.341 |
MOD_Plk_4 | 50 | 56 | PF00069 | 0.360 |
MOD_Plk_4 | 65 | 71 | PF00069 | 0.340 |
MOD_ProDKin_1 | 161 | 167 | PF00069 | 0.245 |
MOD_ProDKin_1 | 202 | 208 | PF00069 | 0.262 |
TRG_DiLeu_BaLyEn_6 | 23 | 28 | PF01217 | 0.484 |
TRG_ENDOCYTIC_2 | 13 | 16 | PF00928 | 0.364 |
TRG_ENDOCYTIC_2 | 228 | 231 | PF00928 | 0.270 |
TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.338 |
TRG_NES_CRM1_1 | 278 | 292 | PF08389 | 0.354 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P455 | Leptomonas seymouri | 35% | 91% |
A0A0N1HTP4 | Leptomonas seymouri | 34% | 100% |
A0A0N1I6V1 | Leptomonas seymouri | 48% | 100% |
A0A0N1IKX5 | Leptomonas seymouri | 68% | 100% |
A0A0S4IQ05 | Bodo saltans | 45% | 91% |
A0A0S4IR22 | Bodo saltans | 38% | 100% |
A0A0S4JRB2 | Bodo saltans | 37% | 97% |
A0A1X0P9F0 | Trypanosomatidae | 46% | 100% |
A0A3Q8IFY7 | Leishmania donovani | 25% | 100% |
A0A3R7NKA0 | Trypanosoma rangeli | 46% | 100% |
A0A3S5H5E4 | Leishmania donovani | 33% | 72% |
A0A3S5H7L8 | Leishmania donovani | 84% | 95% |
A0A3S7WNW6 | Leishmania donovani | 33% | 87% |
A4H418 | Leishmania braziliensis | 39% | 100% |
A4H419 | Leishmania braziliensis | 35% | 100% |
A4H420 | Leishmania braziliensis | 32% | 100% |
A4HHM7 | Leishmania braziliensis | 74% | 100% |
A4HSA1 | Leishmania infantum | 33% | 100% |
A4HSA2 | Leishmania infantum | 33% | 87% |
A4I4U1 | Leishmania infantum | 54% | 95% |
A4I4U2 | Leishmania infantum | 81% | 100% |
A4I816 | Leishmania infantum | 25% | 100% |
C9ZLI8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 100% |
E9AE89 | Leishmania major | 53% | 100% |
E9AE90 | Leishmania major | 80% | 100% |
Q9NF90 | Leishmania major | 32% | 100% |
Q9NF91 | Leishmania major | 36% | 100% |
V5C201 | Trypanosoma cruzi | 43% | 100% |